BENEFITS OF PROPOLIS PERIODONTAL CHIP IN PERIODONTITIS-INDUCED MICE: CLINICAL PARAMETERS AND EXPRESSION OF INTERLEUKIN-1β (IL-1β) EVALUATION
DOI:
https://doi.org/10.22159/ijap.2025.v17s5.12Keywords:
Interleukin-1β, Periodontal propolis chips, Periodontitis, Adjunctive therapy, Periodontal chipAbstract
Objective: Periodontitis is an infection of the tissues that support the teeth. This infection can cause serious damage to the gums, bone, cementum, and periodontal ligaments that hold the teeth in place. Scaling and root planing (SRP) is the standard non-surgical treatment for periodontal disease. This treatment involves removing plaque and calculus from the surfaces of the teeth and roots. Scaling and root planing are effective in eliminating harmful bacteria that cause infection, but they have limitations in reaching deep periodontal pockets and furcation areas. This may necessitate additional antimicrobial therapy to help control the infection. Propolis is a resinous substance produced by bees that has antibacterial and anti-inflammatory properties that have been shown to be beneficial in the treatment of various health conditions. Previous research has shown that 20% hydroalcoholic propolis extract as an additional therapy decreased probing depth score on periodontal pocket. Therefore, this study investigated the efficacy of propolis with lower concentration in reducing inflammation and Interleukin 1-β (IL-1β) levels. This research purposed to analysis the effectiveness of the application of periodontal propolis chip as adjuvant therapy in male Wistar rats on clinical parameters and Interleukin 1-β (IL-1β).
Methods: An experimental laboratory study with a posttest control group design was conducted on 45 male Wistar rats induced with periodontitis using Porphyromonas gingivalis and ligated with silk. The rats were then divided into five treatment groups: placebo group (application of placebo periodontal propolis chip), positive control group (application of 2.5 mg chlorhexidine chip), treatment group 1 (application of 2.5% periodontal propolis chip), treatment group 2 (application of 5% periodontal propolis chip), and treatment group 3 (application of 10% periodontal propolis chip). Clinical parameter assessments (Gingival Index (GI), Bleeding on Probing (BoP), Pocket Depth (PD), Clinical Attachment Loss (CAL)) and IL-1β expression were performed on days 0, 3, and 7 after treatment in the rats.
Results: The results of this study showed significant improvements and decreases in the clinical parameters GI, BoP, PD, and CAL. Examination of IL-1β expression also showed a significant statistical decrease (p<0.05).
Conclusion: The application of a periodontal propolis chip can significantly improve GI, BoP, PD, and CAL and reduce IL-1β expression
References
1. Eke PI, Dye BA, Wei L, Thornton Evans GO, Genco RJ, CDC Periodontal Disease Surveillance Workgroup. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012;91(10):914-20. doi: 10.1177/0022034512457373, PMID 22935673.
2. Nascimento GG, Alves Costa S, Romandini M. Burden of severe periodontitis and edentulism in 2021, with projections up to 2050: the global burden of disease 2021 study. J Periodont Res. 2024;59(5):823-67. doi: 10.1111/jre.13337, PMID 39192495.
3. Wijaksana IK. Periodontal chart and periodontal risk assessment as evaluation and education materials for patients with periodontal. Jurnal Kesehatan Gigi. 2019;6(1):19‑25. doi: 10.31983/jkg.v6i1.4032.
4. Nocini R, Lippi G, Mattiuzzi C. Periodontal disease: the portrait of an epidemic. J Public Health Emerg. 2020;4(1):10. doi: 10.21037/jphe.2020.03.01.
5. Cheng R, Wu Z, Li M, Shao M, Hu T. Interleukin-1β is a potential therapeutic target for periodontitis: a narrative review. Int J Oral Sci. 2020;12(1):2. doi: 10.1038/s41368-019-0068-8, PMID 31900383.
6. Papathanasiou E, Conti P, Carinci F, Lauritano D, Theoharides TC. IL-1 superfamily members and periodontal diseases. J Dent Res. 2020;99(13):1425-34. doi: 10.1177/0022034520945209, PMID 32758110.
7. Joshi D, Garg T, Goyal AK, Rath G. Advanced drug delivery approaches against periodontitis. Drug Deliv. 2016;23(2):363-77. doi: 10.3109/10717544.2014.935531, PMID 25005586.
8. Zhu Y, Liu K, Liu L, Myint S, Wang S, Liu H. Exploring the potential of worldview-2 red-edge band-based vegetation indices for estimation of mangrove leaf area index with machine learning algorithms. Remote Sens. 2017;9(10):1060. doi: 10.3390/rs9101060.
9. Sholapurkar A, Sharma D, Glass B, Miller C, Nimmo A, Jennings E. Professionally delivered local antimicrobials in the treatment of patients with periodontitis-a narrative review. Dent J (Basel). 2020;9(1):2. doi: 10.3390/dj9010002, PMID 33375176.
10. Shah H, Ali A, Patel AA, Abbagoni V, Goswami R, Kumar A. Trends and factors associated with ventilator-associated pneumonia: a national perspective. Cureus. 2022 Mar;14(3):e23634. doi: 10.7759/cureus.23634, PMID 35494935.
11. Etebarian A, Alhouei B, Mohammadi Nasrabadi F, Esfarjani F. Propolis as a functional food and promising agent for oral health and microbiota balance: a review study. Food Sci Nutr. 2024 May 29;12(8):5329-40. doi: 10.1002/fsn3.4216, PMID 39139934, PMCID PMC11317756.
12. Kirti S, Khuller N, Bansal P, Singh P. Clinical and microbiological effects of subgingival irrigation with propolis extract (propolis platinum TM) and chlorhexidine (Periogard®) as an adjunct to scaling and root planing in patients affected with chronic periodontitis a comparative study; 2017. doi: 10.20936/jpbms/171104.
13. Asgharpour F, Moghadamnia AA, Motallebnejad M, Nouri HR. Propolis attenuates lipopolysaccharide-induced inflammatory responses through intracellular ROS and NO levels, along with downregulation of IL-1β and IL-6 expressions in murine RAW 264.7 macrophages. J Food Biochem. 2019;43(8):e12926. doi: 10.1111/jfbc.12926, PMID 31368546.
14. Ozan F, Sumer Z, Polat ZA, Er K, Ozan U, Deger O. Effect of mouthrinse containing propolis on oral microorganisms and human gingival fibroblasts. Eur J Dent. 2007 Oct;1(4):195-201. doi: 10.1055/s-0039-1698339, PMID 19212467, PMCID PMC2609911.
15. Nadhifa TY, Anwaristi AY, Nugrahani NA, Kurniawati D. The effect of coenzim Q10 on the number of lymfocite cells in male wistar rats with periodontitis. Jurnal Edu Health. 2023;14(3):1175-84. doi: 10.54209/jurnaleduhealth.v14i3.2621.
16. Dharmawati IA, Manuaba IB, Thahir H, Bakta IM, Astawa IN, Sukrama DM. Pocket measurement methods in Wistar rats periodontitis induced by bacteria and the installation of silk ligature: an experimental study. Int J Appl Pharm. 2019 Aug;11(4):72. doi: 10.22159/ijap.2019.v11s4.35296.
17. Ayan G, Dayı B. Evaluation of plaque index, gingival index and oral health-related quality of life in obese patiens. Odovtos Int J Dent Sci. 2021;25(1):365-77. doi: 10.15517/ijds.2022.52533.
18. Machorowska Pieniążek A, Skucha Nowak M, Mertas A, Tanasiewicz M, Niedzielska I, Morawiec T. Effects of Brazilian propolis on dental plaque and gingiva in patients with oral cleft malformation treated with multibracket and removable appliances: a comparative study. Evid Based Complement Alternat Med. 2016;2016:2038407. doi: 10.1155/2016/2038407, PMID 27672397.
19. Gunjal S, Pateel DG. Comparative effectiveness of propolis with chlorhexidine mouthwash on gingivitis a randomized controlled clinical study. BMC Complement Med Ther. 2024;24(1):154. doi: 10.1186/s12906-024-04456-8, PMID 38582863.
20. Sanghani NN, Bm S, SS. Health from the hive: propolis as an adjuvant in the treatment of chronic periodontitis a clinicomicrobiologic study. J Clin Diagn Res. 2014;8(9):ZC41-4. doi: 10.7860/JCDR/2014/8817.4856, PMID 25386520.
21. Checchi L, Montevecchi M, Checchi V, Zappulla F. The relationship between bleeding on probing and subgingival deposits an endoscopical evaluation. Open Dent J. 2009;3(1):154-60. doi: 10.2174/1874210600903010154, PMID 19672332.
22. Coutinho A. Honeybee propolis extract in periodontal treatment: a clinical and microbiological study of propolis in periodontal treatment. Indian J Dent Res. 2012;23(2):294. doi: 10.4103/0970-9290.100449, PMID 22945731.
23. Lisbona Gonzalez MJ, Munoz Soto E, Reyes Botella C, Olmedo Gaya MV, Diaz Castro J, Moreno Fernandez J. Study of the antimicrobial effect of an ethanolic extract of propolis in periodontal disease. Appl Sci. 2021;11(16):7463. doi: 10.3390/app11167463.
24. Zulhendri F, Lesmana R, Tandean S, Christoper A, Chandrasekaran K, Irsyam I. Recent update on the anti-inflammatory activities of propolis. Molecules. 2022 Dec 2;27(23):8473. doi: 10.3390/molecules27238473, PMID 36500579.
25. Pahlavani N, Malekahmadi M, Firouzi S, Rostami D, Sedaghat A, Moghaddam AB. Molecular and cellular mechanisms of the effects of Propolis in inflammation, oxidative stress and glycemic control in chronic diseases. Nutr Metab (Lond). 2020 Aug 12;17:65. doi: 10.1186/s12986-020-00485-5, PMID 32817750.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
